A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Metabolic alterations in patients with prostate cancer treated with androgen deprivation with/without normalization of testosterone levels
Reports of Practical Oncology & Radiotherapy
Objectives. To compare the incidence of metabolic alterations (hypercholesterolemia >200 mg/dl, hypertriglyceridemia >175 mg/dl and hyperglycemia >110 mg/dl) in patients (pts) with prostate cancer (PCa) treated with androgen deprivation therapy (ADT) with/without normalization of testosterone levels (NTL). Materials and methods. Retrospective analysis of 304 pts with PCa, treated with ADT and radiotherapy in our hospital from October 2001 to December 2009, to compare the incidence of metabolicdoi:10.1016/j.rpor.2013.03.497 fatcat:btyzbhako5eqdjoe4mdm3m3fzm